Sort
78,016 grants matching “breast cancer”
Discovery of Risk Loci and Genomics of Pancreatic Cancer through Exome Sequencing
$997,116Paul A Scheet · University Of Tx Md Anderson Can Ctr · R01 · FY2019 · CA
HELPING THE MOTHER WITH BREAST CANCER SUPPORT HER CHILD
$997,108University Of Washington · R01 · FY2002 · CA
ACHIEVING BETTER CANCER DIAGNOSIS (ABCD): Identifying, supporting, and learning from marginalized patients who experience delayed cancer diagnosis
$996,882Gordon David Schiff · Brigham And Women'S Hospital · R18 · FY2022 · HS
Late Effects of Treatment in Wilms Tumor Survivors and Offspring
$996,733Norman E Breslow · Fred Hutchinson Cancer Research Center · R01 · FY2008 · CA
Biology and genetics of metastatic disease
$996,660Sohail F. Tavazoie · Rockefeller University · R35 · FY2023 · CA
Tracking the evolution of breast cancer through single cell analyses of premalignant breast tissues from women at high risk for cancer development
$996,660Joan Siefert Brugge · Harvard Medical School · R35 · FY2022 · CA
Tracking the evolution of breast cancer through single cell analyses of premalignant breast tissues from women at high risk for cancer development
$996,660Joan Siefert Brugge · Harvard Medical School · R35 · FY2023 · CA
Detecting breast cancer with a simple blood test using an accessible and low-cost novel real-time platform
$996,518Eagappanath Thiruppathi · Inanovate, Inc. · R44 · FY2018 · CA
Breast CT scanner for earlier cancer detection
$996,354University Of California Davis · R01 · FY2004 · EB
PDX Trial Center for Breast Cancer Therapy
$996,258Alana L Welm · University Of Utah · U54 · FY2024 · CA
Liver Specific Manganese Based MRI Contrast Agent
$996,175Vera Hoffman · Reveal Pharma · R44 · FY2020 · CA
Molecular, Cellular, and Tissue Characterization Unit
$996,148William E Gillanders · Washington University · U2C · FY2018 · CA
PREVENTION OF TRIPLE-NEGATIVE BREAST CANCER BY NATURAL COMPOUNDS
$996,063University Of Kansas Medical Center Research Institute, Inc. · · FY2018 · Defense Health Agency
PNNL Proteome Characterization Center
$995,930Tao Liu · Battelle Pacific Northwest Laboratories · U24 · FY2019 · CA
Stalled replication fork repair in cancer predisposition and cancertherapy
$995,896Ralph Scully · Beth Israel Deaconess Medical Center · R35 · FY2023 · CA
Carle Cancer Center Community Clinical Oncology Program
$995,842Kendrith Martin Rowland · Carle Foundation · U10 · FY2006 · CA
SBIR TOPIC283: DEVELOPMENT OF A MOLECULAR DIAGNOSTIC ASSAY TO DETECT BASAL-LIKE B
$995,819Tania Ray · Onconostic Technologies, Inc. · N44 · FY2013 · CA
Development of TIMP-2 derivatives or strategies as biologic therapies for cancer
$995,769William Stetler-Stevenson · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
Koning Cone Beam Breast CT
$995,670David L Conover · Koning Corporation · R44 · FY2010 · CA
Along the continuum for an IND: An In-Vivo large animal study for opticalimage guided surgery of spontaneous breast cancer.
$995,636Brian Straight · Akrotome Imaging, Inc. · R44 · FY2022 · CA
Fluorescein for Sentinel Lymph Node Detection
$995,474James M McGreevy · Vestan, Inc. · R42 · FY2012 · CA
Spectroscopic Localization of Breast Cancer
$995,474David A. Benaron · Spectros Corporation · R44 · FY2007 · CA
Continued studies of environment impact on puberty
$995,396Frank M Biro · Cincinnati Childrens Hosp Med Ctr · U01 · FY2010 · ES
Development of anti-sense oligonucleotides as a therapeutic for cancer pain through selective block of sodium channel pain targets
$995,305Hongkang Zhang · Quiver Bioscience Inc. · R44 · FY2022 · CA
VDX-111: A novel targeted therapeutic for triple-negative breast cancer
$995,137Cherie Lambert · Vona Oncology, Llc · R44 · FY2024 · CA